Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAurobindopharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Mid & smallcap stocks look expensive! 10 largecap which could give 40% return

      The liquidity drive which pushed benchmark indices to record highs also pushed many stocks especially in the small and midcap space to valuations beyond their historic averages.

    • Sell Aurobindo Pharma, Coal India; Buy Gati: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may sell Aurobindo Pharma and Coal India.

    • Buy Zee Entertainment Enterprises; sell Aurobindo Pharma: Mitessh Thakkar

      Mitessh Thakkar of mitesshthakkar.com suggests selling Aurobindo Pharma.

    • Hold Aurobindo Pharma, says Shahina Mukadam

      Shahina Mukadam, Independent Market Expert is of the view that one may hold Aurobindo Pharma.

    • Hold Aurobindo Pharma, may test Rs 870: Sandeep Wagle

      Sandeep Wagle of powermywealth.com is of the view that one may hold Aurobindo Pharma.

    • Top buy & sell ideas by Ashwani Gujral & Mitessh Thakkar for January 3

      Mitessh Thakkar of mitesshthakkar.com recommends buying HCL Tech with a stop loss of Rs 876 for target of Rs 922 and a buy on Marico with a stop loss of Rs 319 for target of Rs 338.

    • Sell Aurobindo Pharma, Indiabulls Real Estate, Adani Ports; buy Tata Motors: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com is of the view that one can sell Aurobindo Pharma, Indiabulls Real Estate and Adani Ports and can buy Tata Motors.

    • Hold Sun Pharma, says Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that one my hold Sun Pharma.

    • Prefer Natco Pharma, says Gaurang Shah

      Gaurang Shah of Geojit Financial Services is of the view that one may prefer Natco Pharma.

    • Buy Aurobindo Pharma, Voltas; JSPL may test Rs 240-250: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com advises buying Aurobindo Pharma, Voltas and Sun Pharmaceutical Advanced Research Company.

    • Buy HDFC Bank, Lupin, Larsen & Toubro, Delta Corp: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com recommends buying HDFC Bank, Lupin, Larsen & Toubro and Delta Corp.

    • Buy Sonata Software, United Breweries, SAIL, Aurobindo Pharma, Balrampur Chini: Mitessh Thakkar

      Mitessh Thakkar of mitesshthakkar.com recommends buying Sonata Software, United Breweries, SAIL, Aurobindo Pharma and Balrampur Chini.

    • Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar & Prakash Gaba for Dec 12

      Mitessh Thakkar of miteshthacker.com advises buying Aurobindo Pharma with a target of Rs 710.

    • Hold Alkem Laboratories: Mayuresh Joshi

      Mayuresh Joshi of Angel Broking is of the view that one may hold Alkem Laboratories.

    • Prefer Aurobindo Pharma: Gaurang Shah

      Gaurang Shah of Geojit Financial Services is of the view that one may prefer Aurobindo Pharma.

    • Top 11 largecap stocks which are likely to remain in action in December series; do you own any?

      At the current juncture, 10,000 put and 10,500 call options are attracting trader’s attention and will remain in a range for the index for the few sessions.

    • Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar & Prakash Gaba for December 4

      Mitessh Thakkar of miteshthacker.com suggests buying Dish TV with a stop loss of Rs 79 for target of Rs 83 and advises buying NBCC with a stop loss of Rs 254.90 for target of Rs 272 while he recommends selling Tata Communications around Rs 684, stop loss of Rs 696 for target of Rs 660.

    • Nifty likely to open higher with support at 10094; 4 top stocks to trade today: Prakash Gaba

      According to Technical Analyst Prakash Gaba of prakashgaba.com, the Nifty still looks weak and the next logical target on the downside is 10013 while stiff resistance is at 10260. The crucial support for the Nifty is at 10094-10013 and the resistance is at 10260. Bank Nifty on the other hand has support at 24782-25030 and resistance at 25400.

    • Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar & Prakash Gaba for December 1

      Ashwani Gujral of ashwanigujral.com recommends a buy on Radico Khaitan with a stop loss of Rs 280, for target of Rs 305 and a buy on Balkrishna Industries with a stop loss of Rs 2100, target of Rs 2250.

    • Exit Granules India on rallies: Shahina Mukadam

      Shahina Mukadam, Independent Market Expert is of the view that one may exit Granules India on rallies.

    • Top buy & sell ideas by Ashwani Gujral,Mitessh Thakkar & Prakash Gaba for November 27

      Ashwani Gujral of ashwanigujral.com has a buy on Titan Company with a stop loss of Rs 820, target of Rs 855 and DLF with a stop loss of Rs 224, target of Rs 238.

    • Nifty likely to open gap down with support at 10300; buy Aurobindo Pharma, sell PVR: Prakash Gaba

      According to Technical Analyst Prakash Gaba of prakashgaba.com, the trend is still up and the next logical target is 10585 as long as 10260 holds. The crucial support for the Nifty is at 10300-10260 and the resistance is at 10410-10585. Bank Nifty on the other hand has support at 25600 and resistance at 26000.

    • ITC can climb to around Rs 268: Prakash Gaba

      Prakash Gaba of prakashgaba.com feels that ITC can climb to around Rs 268.

    • Buy Automotive Axles on dips: Prakash Gaba

      Prakash Gaba of prakashgaba.com advises buying Automotive Axles on dips.

    • Buy PG Foils: SP Tulsian

      In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his readings and outlook on market and specific stocks.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347